Condition
Severe Sepsis Without Septic Shock
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Enrolling By Invitation1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05304728Enrolling By Invitation
Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol
NCT02339649Not ApplicableUnknown
Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their Predictors
NCT02135770Phase 3Completed
Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis
Showing all 3 trials